Online citations, reference lists, and bibliographies.
← Back to Search

Impact Of Polymers On The Aggregation Of Wet-milled Itraconazole Particles And Their Dissolution From Spray-dried Nanocomposites

E. Bilgili, M. Rahman, D. Palacios, Faustin Arevalo
Published 2018 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract We explore the impact of various polymers and their molecular weight on the stabilization of wet-milled suspensions of itraconazole (ITZ), a poorly soluble drug, and its dissolution from spray-dried suspensions. To this end, ITZ suspensions with SSL, SL, and L grades of hydroxypropyl cellulose (HPC) having molecular weights (MWs) of 40, 100, and 140 kg/mol, respectively, hydroxypropyl methyl cellulose (HPMC E3 with 10 kg/mol), polyvinylpyrrolidone (PVP K30 with 50 kg/mol), sodium dodecyl sulfate (SDS, surfactant), and HPC SL–SDS were wet media milled and spray-dried. Laser diffraction results show that 2.5% HPC SL–0.2% SDS led to the finest ITZ nanosuspension, whereas without SDS, only 4.5% HPC with SL/L grades ensured minimal aggregation. Rheological characterization reveals that aggregated suspensions exhibited pronounced pseudoplasticity, whereas stable suspensions exhibited near Newtonian behavior. Spray-drying yielded nanocomposites with 60–78% mean ITZ loading and acceptable content uniformity. Severe aggregation occurred during milling/drying when 4.5% polymers with MW ≤ 50 kg/mol were used; their nanocomposites exhibited incomplete redispersion due to slow matrix erosion and released ITZ slowly during dissolution test. Overall, high drug-loaded, surfactant-free ITZ nanocomposites that exhibited immediate release (>80% dissolved in 20 min) were prepared via spray-drying of wet-milled ITZ with 4.5% HPC SL/L.
This paper references
10.1016/j.ejpb.2015.05.028
Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer.
Mohammad A Azad (2015)
10.1016/S0032-5910(99)00159-X
The influence of suspension properties on ultra-fine grinding in stirred ball mills
C. Bernhardt (1998)
10.1016/j.ijpharm.2007.12.032
Characteristics of polymers enabling nano-comminution of water-insoluble drugs.
J. Lee (2008)
10.1016/j.ejpb.2011.03.014
Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
S. Singh (2011)
10.1002/jps.21786
Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.
M. Lee (2009)
10.2131/JTS.25.49
Histopathological study of the effects of a single intratracheal instillation of surface active agents on lung in rats.
M. Suzuki (2000)
10.1002/9783527631728.CH21
Fundamentals of Energy Analysis of Dryers
Ir. Ian C. Kemp (2012)
10.1016/J.COSSMS.2012.10.004
Nanocrystals for the parenteral delivery of poorly water-soluble drugs.
B. Sun (2012)
10.1002/jps.24098
A brief literature and patent review of nanosuspensions to a final drug product.
W. W. Chin (2014)
10.1016/j.ejpb.2013.12.016
Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs.
L. de Smet (2014)
10.1016/j.ejps.2012.04.020
Application of spray granulation for conversion of a nanosuspension into a dry powder form.
S. Bose (2012)
10.3109/03639045.2012.676048
Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect
A. Monteiro (2013)
10.1016/j.ijpharm.2008.07.023
Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.
B. Van Eerdenbrugh (2008)
10.1016/J.CES.2004.12.057
Agglomeration and breakage of nanoparticles in stirred media mills : a comparison of different methods and models
M. Sommer (2006)
10.3109/03639045.2014.914528
Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation
W. Sun (2015)
10.1295/POLYMJ.22.482
The Interaction of Sodium Dodecylsulfate with (Hydroxypropyl)Cellulose
F. Winnik (1990)
10.1016/J.JCONREL.2007.01.016
Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
G. Mittal (2007)
10.1016/j.addr.2010.12.007
Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
E. Merisko-Liversidge (2011)
10.1201/9780849374555
Nanoparticle technology for drug delivery
R. B. Gupta (2006)
10.1007/s11095-007-9475-1
Pharmaceutical Particle Engineering via Spray Drying
R. Vehring (2007)
10.1016/S1672-2515(07)60032-3
Production of pigment nanoparticles using a wet stirred mill with polymeric media
E. Bilgili (2004)
10.1177/0192623307310946
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
E. Merisko-Liversidge (2008)
10.1002/JPS.10471
Drug nano- and microparticles processed into solid dosage forms: physical properties.
J. Lee (2003)
10.22377/AJP.V9I3.423
Spray drying of nanoparticles to form fast dissolving glipizide
A. Vatanara (2015)
10.1016/j.ejps.2013.09.002
Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
A. Afolabi (2014)
10.1021/LA026430F
Coadsorption of Sodium Dodecyl Sulfate with Hydrophobically Modified Nonionic Cellulose Polymers. 2. Role of Surface Selectivity in Adsorption Hysteresis
K. Berglund (2003)
10.1016/j.ejpb.2010.12.002
Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
Tobias Lebhardt (2011)
10.1023/A:1022678505433
A New Understanding of the Relationship Between Solubility and Particle Size
W. Wu (1998)
10.1016/J.CHERD.2013.02.008
A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves
C. Knieke (2013)
10.1021/LA026429G
Coadsorption of Sodium Dodecyl Sulfate with Hydrophobically Modified Nonionic Cellulose Polymers. 1. Role of Polymer Hydrophobic Modification
K. Berglund (2003)
10.1016/0168-3659(87)90035-6
A simple equation for description of solute release II. Fickian and anomalous release from swellable devices
P. L. Ritger (1987)
10.3109/03639045.2011.637051
Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption
Yusuke Tanaka (2012)
10.3109/9781420017267
Oral lipid-based formulations : enhancing the bioavailability of poorly water-soluable drugs
D. Hauss (2007)
10.1016/j.ijpharm.2010.07.010
Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions.
Sujung Kim (2010)
10.1016/j.jconrel.2014.02.016
Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
Annika Sarnes (2014)
10.1016/j.ijpharm.2013.11.059
Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
A. Bhakay (2014)
10.1016/J.APT.2016.05.026
A study of the impact of polymer–surfactant in drug nanoparticle coated pharmatose composites on dissolution performance
M. Li (2016)
10.1021/MA961552Y
Microviscosity in Clusters of Ethyl Hydroxyethyl Cellulose and Sodium Dodecyl Sulfate Formed in Dilute Aqueous Solutions As Determined with Fluorescence Probe Techniques
H. Evertsson (1997)
Analysis of Fickian and non-Fickian drug release from polymers.
N. Peppas (1985)
An investigation on wetting of porous materials
D. Hołownia (2008)
10.1016/0378-5173(95)00122-Y
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
G. Liversidge (1995)
10.3109/03639045.2014.976574
Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites
Mohammad A Azad (2015)
10.1016/J.EJPB.2004.03.001
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
Marc Lindenberg (2004)
10.1080/10717540802039113
Effect of Polymer Molecular Weight on Nanocomminution of Poorly Soluble Drug
Ji-Yeun Choi (2008)
10.1103/PHYSREV.17.273
The Dynamics of Capillary Flow
E. Washburn (1921)
10.1016/0378-5173(86)90197-3
The effect of the molecular weight of ethyl cellulose on the drug release properties of mixed films of ethyl cellulose and hydroxypropylmethylcellulose
R. Rowe (1986)
10.1007/s11095-011-0465-y
Design of Dry Nanosuspension with Highly Spontaneous Dispersible Characteristics to Develop Solubilized Formulation for Poorly Water-Soluble Drugs
T. Niwa (2011)
10.1016/j.ijpharm.2016.09.046
Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
Mohammad A Azad (2016)
10.1016/J.IJPHARM.2007.02.005
Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling.
B. Van Eerdenbrugh (2007)
10.1023/A:1016212804288
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
G. Amidon (2004)
10.1016/j.ijpharm.2011.02.051
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Indrajit K. Ghosh (2011)
10.1016/J.ADDR.2007.05.003
Nanosizing--oral formulation development and biopharmaceutical evaluation.
F. Kesisoglou (2007)
10.1016/j.ijpharm.2017.04.012
Downstream drug product processing of itraconazole nanosuspension: Factors influencing drug particle size and dissolution from nanosuspension-layered beads.
J. Parmentier (2017)
Stabilizers used in nano-crystal based drug delivery systems.
G. Shete (2014)
10.1155/2013/848043
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
S. Gupta (2013)
10.3109/03639045.2010.551775
Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs
A. Bhakay (2011)
10.1208/s12249-015-0364-3
An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions
Meng Li (2015)
10.1016/j.ijpharm.2009.05.038
In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug.
J. Boateng (2009)
10.1002/CEAT.201300355
Concentrated Fenofibrate Nanoparticle Suspensions from Melt Emulsification for Enhanced Drug Dissolution
C. Knieke (2014)
10.1016/S0009-2509(03)00133-7
Particle size distributions and viscosity of suspensions undergoing shear-induced coagulation and fragmentation
G. Barthelmes (2003)
10.1016/J.EJPB.2006.01.015
Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
W. Abdelwahed (2006)
10.3109/10837450.2015.1022788
Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
E. Bilgili (2016)
10.3109/03639045.2013.831442
Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants
A. Bhakay (2014)
10.1002/JPS.20979
Effect of polymer molecular weight on the production of drug nanoparticles.
S. Sepassi (2007)
10.1002/JPS.10126
Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.
J. Peeters (2002)
10.1016/j.drudis.2018.01.016
Pharmaceutical nanocrystals: production by wet milling and applications.
M. Malamatari (2018)
10.1016/J.EJPB.2005.05.009
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
C. Keck (2006)
10.1016/j.ijpharm.2011.12.045
A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Y. Wang (2012)
10.1081/DRT-200047900
Progress in Drying Technology for Nanomaterials
Baohe Wang (2005)
10.1016/S0065-2377(08)60194-5
Interactions between colloidal particles and soluble polymers
H. Ploehn (1990)
10.1016/j.ejps.2013.07.011
Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
T. Niwa (2013)
10.3390/pharmaceutics8020017
Nanomilling of Drugs for Bioavailability Enhancement: A Holistic Formulation-Process Perspective
Meng Li (2016)
10.1080/03639040802005024
Production and In Vitro Characterization of Solid Dosage form Incorporating Drug Nanoparticles
Shradhanjali Basa (2008)
10.1016/j.ejpb.2008.06.007
Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole.
B. Van Eerdenbrugh (2008)
10.1021/J100721A006
Viscosity of water at various temperatures
L. Korson (1969)
10.1016/j.ejps.2008.08.003
Alternative matrix formers for nanosuspension solidification: Dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion.
B. Van Eerdenbrugh (2008)
10.1016/j.ejpb.2017.06.003
A comparative assessment of nanocomposites vs. amorphous solid dispersions prepared via nanoextrusion for drug dissolution enhancement
M. Li (2017)
Techniques of solubilization of drugs
S. Yalkowsky (1981)
10.1016/j.ijpharm.2010.06.020
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.
Ana M Cerdeira (2010)
10.1111/j.2042-7158.2010.01022.x
Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods
L. Peltonen (2010)
10.1208/s12249-018-0993-4
Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms
M. Li (2018)
10.1016/j.ejps.2008.06.009
Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
B. Van Eerdenbrugh (2008)
10.1016/j.ijpharm.2014.03.048
Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
A. Tuomela (2014)
10.6028/JRES.049.011
A Viscometric Study of the Micelles of Sodium Dodecyl Sulfate in Dilute Solutions
L. M. Kushner (1952)
10.1021/JA02086A003
The rate of solution of solid substances in their own solutions
A. A. Noyes (1897)
10.1016/j.ijpharm.2010.11.021
Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Wean Sin Cheow (2011)
10.1016/j.ejpb.2012.04.020
Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
P. Kayaert (2012)
10.3390/pharmaceutics10030086
Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation–Processing Aspects and Challenges
A. Bhakay (2018)
10.1016/J.POWTEC.2011.12.066
Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating
A. Bhakay (2013)
10.1016/j.addr.2011.03.011
Production methods for nanodrug particles using the bottom-up approach.
H. Chan (2011)
10.1016/j.ijpharm.2012.09.040
A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling.
E. Bilgili (2012)
10.1016/S0928-0987(01)00095-1
Modeling and comparison of dissolution profiles.
P. Costa (2001)
10.1016/0168-3659(87)90034-4
A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs
P. L. Ritger (1987)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar